Investor Update

Basel, 07 September 2018

Baloxavir Marboxil Phase II and III Studies for the Treatment of Influenza Published in the New England Journal of Medicine

Dear Investor,

Please find attached a press release by Shionogi & Co., Ltd.

Do not hesitate to contact us for any further questions.